Design of a Targeted Covalent Probe to Interrogate the DNA Polymerase Activity of Polθ
Human DNA polymerase θ (Polθ) is essential for microhomology-mediated end-joining (MMEJ) and represents a therapeutic vulnerability in homologous recombination (HR)-deficient cancers. Although reversible inhibitors of Polθ have advanced into clinical development, covalent chemical probes remain unexplored. Analysis of a previously described structure of the reversible inhibitor <b>compound 37</b> bound to Polθ identified Cys2411 as an accessible residue 7.4 Å adjacent to the inhibitor binding site. Guided by X-ray crystallographic studies, we designed <b>compound 29</b> to reduce the separating distance between inhibitor and Cys2411 to 4.7 Å and then synthesized <b>RP-4029</b> by incorporating a vinyl sulfone electrophile. Functional studies revealed efficient covalent linkage to Cys2411 (<i>K</i> <sub>inact</sub> = 11.6 s<sup>-1</sup>), while a high-resolution (2.0 Å) cocrystal structure validated the design strategy. These findings establish Cys2411 as a privileged site for covalent inhibitor development and provide a highly potent, selective chemical probe useful for investigating Polθ biology.
Authors
- Stephen Orlicky (ORCID: https://orcid.org/0000-0002-8172-2042)
- P. Mäder (ORCID: https://orcid.org/0000-0002-0820-2761)
- Claude Godbout
- Michal Zimmermann (ORCID: https://orcid.org/0000-0002-9955-1675)
- Yaël Mamane
- Martine Hamel
- Michael J. Zinda (ORCID: https://orcid.org/0009-0002-1394-2032)
- Alexander L. Perryman
- Agnel J. Sfeir (ORCID: https://orcid.org/0000-0003-1633-8535)
- Igor Kurinov (ORCID: https://orcid.org/0000-0001-5472-5574)
- Cassandra Wong
- Daniel Durocher (ORCID: https://orcid.org/0000-0003-3863-8635)
- Michel Gallant
- Jean-Pierre Falgueyret
- Stephen J. Morris
- Monica Bubenik
- Frank Sicheri
- Anne Claude Gingras
- W. Cameron Black
Institutions
- University of Toronto (CA)
- Cornell University (US)
- Lunenfeld-Tanenbaum Research Institute (CA)
- Kettering University (US)
- Io Therapeutics (United States) (US)
Publication Details
- Journal
- ACS Medicinal Chemistry Letters
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1021/acsmedchemlett.5c00643
- Primary Topic
- DNA Repair Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00